Cover Image

A1 milk and its controversy-a review

Abhishek Parashar*, Ram Krishan Saini

Abstract


Milk is divided into two group’s type A1 and type A2 on the basis of betacasomorphin-7 (BCM-7) production. Type A1 milk on enzymatic digestion produces BCM-7 but A2 does not. This is because of mutation that changed proline to histidine at position number 67 in β-casein of type A1 milk. BCM-7 is a seven amino acid long peptide and speculated to be involved in aggravating non-communicable disorders such as juvenile diabetes, autism and schizophrenia. Gut enzymes such as pepsin, leucine aminopeptidase, elastase, trypsin and pancreatin could produce BCM-7 form β-casein of A1 milk on its digestion, as infant gut system has more intestinal permeability for nutrient; the passage of BCM-7 in serum is possible. The same could also happen in patients having leaky gut syndrome. Although presence of dipeptidyl peptidase (IV) enzymes on the surface of enterocytes and serum degrades BCM-7 to smaller peptides, further less permeability of gut in adults reduces the chance of passage of BCM-7 from gut to serum. Statistical data are correlating BCM-7 for non-communicable disorders, but animal studies and human studies are still not conclusive in this regard. India is largest producer of milk and majority of milk is of A2 type. However, crossbreds having high milk producing capacity have A1 allele in their genome, which requires its careful monitoring. Further, research is needed in knowing A1 milk effects on Indian population.

Keywords


A1 milk; A2 milk; β-casein; Betacasomorphin-7; Opioid.

Full Text:

PDF

References


Ng-Kwai-Hang, KF, F Grosclaude. “Genetic polymorphism of milk proteins.” In Fox PF and McSweeney PLH (eds), Advanced Dairy Chemistry, Chapter 16 (2002): 737-814, Kluwer Academic/Plenum Publishers, New York. Print

EFSA Scientific Report. “DATEX working group on the potential health impact of beta-casomorphins and related peptides.” 231(2009): 1-107. Print

Mishra, BP, M Mukesh, B Prakash, M sodhi, R Kapila, A Kishore, RR Kataria, BK Joshi, V Bhasin, TJ Rasool, KM Bujarbaruah. “Status of milk protein, beta-casein variants among Indian milch animals.” Indian Journal of Animal Sciences. 79.7 (2009): 722-725. Print

Raies, H, R Kapila, UK Shandilya, AK Dang, S Kapila. “Detection of A1 and A2 genetic variants of beta-casein in Indian crossbred cattle by PCR-ACRS.” Milchwissenschaft- Milk Science International. 67.4 (2012): 396-398. Print

Jinsmaa, Y, M Yoshikawa. “Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein.” Peptides. 20.8 (1999): 957-962. Print

Cade, R, M Privette, M Fregly, N Rowland, S Zhongjie, V Zele, H Wagemaker, C Edelstein. “Autism and schizophrenia: intestinal disorders.” Nutritional Neuroscience. 3.1 (2000): 57-72. Print

Egleton, RD, TP Davis. “Development of neuropeptide drugs that cross the blood-brain barrier.” NeuroRx. 2.1 (2005): 44-53. Print

Egleton, RD, TP Davis. “Bioavailability and transport of peptides and peptide drugs into the brain.” Peptides. 18.9 (1997): 1431-1439. Print

Ganapathy, V, S Miyauchi. “Transport systems for opioid peptides in mammalian tissues.” The AAPS Journal. 7.4 (2005): 852-856. Print

Hu, H, S Miyauchi, CC Bridges, SB Smith, V Ganapathy. “Identification of a novel Na+-and Cl-- coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat.” Biochemical Journal. 375.1(2003):17-22. Print

Fogh, J, WC Wright, JD Loveless. “Absence of HeLa cell contamination in 169 cell lines derived from human tumors.” Journal of the National Cancer Institute. 58.2 (1977): 209-214. Print

Pinto, M, S Robine-Leon, MD Appay, M Kedinger, N Triadou, E Dussaulx, B Lacroix, P Simon-Assmann, K Haffen, J Fogh. “Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture.” Biology of the Cell. 47.3 (1983): 323-330. Print

Iwan, M, B Jarmolowska, E Kostyra, M Kaczmarski. “Transport of μ-opioid receptor agonists and antagonist peptides across Caco-2 monolayer.” Peptides. 29.6 (2008):1042-1047. Print

Singh, M, CL Rosen, K Chang, GG Haddad. “Plasma betacasomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs.” Pediatric Research. 26.1 (1989): 34. Print

De Noni, I. “Release of beta-casomorphins 5 and 7 during simulated gastro-intestinal digestion of bovine beta-casein variants and milk-based infant formulas.” Food Chemistry. 110.4 (2008): 897-903. Print

Hamosh, M. “Digestion in the newborn.” Clinics in Perinatology. 23.2 (1996): 191-209. Print

Berseth, CL, PJ Thureen, WW Hay. “Development and physiology of the gastrointestinal tract.” Neonatal Nutrition and Metabolism. 2 (2006): 67-73. Print

Laugesen, M, R Elliott. “Ischaemic heart disease, type 1 diabetes and cow milk A1 beta-casein.” Journal of the New Zealand Medical Association. 116.1168 (2003). Print

McLachlan, CNS. “Beta-casein A1, ischaemic heart disease mortality and other illnesses.” Medical Hypotheses. 56.2 (2001): 262-272. Print

Birgisdottir, BE, JP Hill, DP Harris, I Thorsdottir. “Variation in consumption of cow milk proteins and lower incidence of Type 1 diabetes in Iceland vs the other 4 Nordic countries.” Diabetes, Nutrition & Metabolism.15.4 (2002):240-245. Print

Elliott, RB, DP Harris, JP Hill, NJ Bibby, HE Wasmuth. “Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption.” Diabetologia. 42.3 (1999): 292-296. Print

IUPHAR 2008. “The IUPHAR Database on Receptor Nomenclature and Drug Classification.” http://www.iuphar-db.org/GPCR/Receptor List Forward. Online

Brantl, V, H Teschemacher, A Henschen, F Lottspeich. “Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone.” Hoppe-Seyler's Zeitschrift fur Physiologische Chemie. 360.9 (1979): 1211-1216. Print

Henschen, A, F Lottspeich, V Brantl, H Teschemacher. “Novel opioid peptides derived from casein (betacasomorphins). II. Structure of active components from bovine casein peptone.” Hoppe-Seyler's Zeitschrift fur Physiologische Chemie. 360.9 (1979): 1217-1224. Print

Brantl, V, H Teschemacher, J Blasig, A Henschen, F Lottspeich. “Opioid activities of betacasomorphins.” Life Sciences. 28.17(1981): 1903-1909. Print

Barnett, MP, WC McNabb, NC Roy, KB Woodford, AJ Clarke. “Dietary A1 beta-casein affects gastrointestinal transit time, dipeptidyl peptidase-IV activity, and inflammatory status relative to A2 β-casein in Wistar rats.” International Journal of Food Sciences and Nutrition. 65.6 (2014): 720-727. Print

Sakaguchi, M, M Koseki, M Wakamatsu, E Matsumura. “Effects of betacasomorphin-5 on passive avoidance response in mice.” Bioscience, Biotechnology and Biochemistry. 67.11 (2003a): 2501-2504. Print

Taira, T, LA Hilakivi, J Aalto, I Hilakivi. “Effect of beta-casomorphin on neonatal sleep in rats.” Peptides (New York, NY. 1980). 11.1 (1990): 1-4. Print

Koch, G, K Wiedemann, H Teschemacher. “Opioid activities of human betacasomorphins.” Naunyn-Schmiedeberg's Archives of Pharmacology. 331.4 (1985): 351-354. Print

Jarmolowska, B, K Sidor, M Iwan, K Bielikowicz, M Kaczmarski, E Kostyra, H Kostyra. “Changes of betacasomorphin content in human milk during lactation.” Peptides. 28.10 (2007a): 1982-1986. Print

Meisel, H, RJ FitzGerald. “Opioid peptides encrypted in intact milk protein sequences.” British Journal of Nutrition. 84.1 (2000): 27-31. Print

Ul Haq, MR, R Kapila, V Saliganti. “Consumption of β-casomorphins-7/5 induce inflammatory immune response in mice gut through Th2 pathway.” Journal of Functional Foods. 8.1 (2014): 150-160. Print

Pol, O, M Sasaki, N Jimenez, VL Dawson, TM Dawson, MM Puig. “The involvement of nitric oxide in the enhanced expression of μ-opioid receptors during intestinal inflammation in mice”. British Journal of Pharmacology 145.6 (2005):758-766. Print

Knivsberg, AM, KL Reichelt, T Hoen, M Nodland. “A randomized, controlled study of dietary intervention in autistic syndromes.” Nutritional Neuroscience. 5.4 (2002): 251-261. Print

Bernard, S, A Enayati, L Redwood, H Roger, T Binstock. “Autism: a novel form of mercury poisoning.” Medical Hypotheses. 56.4 (2001): 462-471. Print

Reichelt, KL, K Hole, A Hamberger, G Saelid, PD Edminson, CB Braestrup, O Lingjaerde, P Ledaal, H Orbeck..“Biologically active peptide containing factors in schizophrenia and childhood autism.” Advances in Biochemical Psychopharmacology. 28 (1981): 627-643. Print

Huebner, FR, KW Lieberman, RP Rubino, JS Wall. “Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates.” Peptides. 5.6 (1984): 1139-1147. Print

Annotated Bibliography: Adverse health effects related to mercury and amalgam fillings and clinically documented recoveries after amalgam replacement. www.flcv.com/amalg6.html. Online

Wasilewska, J, E Sienkiewicz-Szłapka, E Kuz´bida, B Jarmołowska, M Kaczmarski, E Kostyra. “The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE)”. Neuropeptides. 45.3 (2011): 189-195. Print

Swinburn, B. “Beta-casein A1 and A2 in milk and human health Report to New Zealand Food Safety Authority.” Prepared for New Zealand Food Safety Authority. 2004. Print

Dai, YD, IG Marrero, P Gros, H Zaghouani, LS Wicker, EE Sercarz. “Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.” Diabetes. 58.1 (2009): 156–164. Print

Pozzilli, P. “Beta-casein in cow’s milk: a major antigenic determinant for type 1 diabetes?.” Journal of Endocrinological Investigation. 22.7 (1999): 562-567. Print

Cavallo, MG, D Fava, L Monetini, F Barone, P Pozzilli. “Cell-mediated immune response to beta-casein in recent-onset insulin dependent diabetes: implications for disease pathogenesis.” Lancet. 348.9032 (1996b): 926-928. Print

Inman, LR, CT McAllister, L Chen, S Hughes, CB Newgard, JR Kettman, RH Unger, JH Johnson. “Autoantibodies to the GLUT-2 glucose transporter of beta cells in insulin dependent diabetes mellitus of recent onset.” Proceedings of the National Academy of Sciences of the United States of America. 90.4 (1993): 1281-1284. Print

Beales, P, R Elliott, S Flohé, J Hill, H Kolb, P Pozzilli, GS Wang, H Wasmuth, F Scott. “A multi-centre, blinded international trial of the effect of A1 and A2 betacasein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes.” Diabetologia. 45.9 (2002): 1240-1246. Print

Allison, AJ, AJ Clarke. “Further research for consideration in 'the A2 milk case'.” European Journal of Clinical Nutrition. 60.7 (2006): 921-924. Print

Kajikawa, M, T Ohta, M Takase, K Kawase, S Shimamura, I Matsuda. “Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteins.” Biochimica et Biophysica Acta. 1213.1 (1994):82-90. Print

Suzukawa, M, M Abbey, P Clifton, PJ Nestel. “Enhanced capacity of n-3 fatty acid–enriched macrophages to oxidize low density lipoprotein mechanisms and effects of antioxidant vitamins.” Atherosclerosis. 124.2 (1996):157-169. Print

Tailford, KA, CL Berry, AC Thomas, JH Campbell. “A casein variant in cow's milk is atherogenic.” Atherosclerosis. 170.1 (2003): 13-19. Print

Keating, AF, TJ Smith, RP Ross, MT Cairns. “A note on the evaluation of a beta-casein variant in bovine breeds by allele-specific PCR and relevance to beta-casomorphin.” Irish Journal of Agricultural and Food Research. 47.1 (2008): 99-104. Print

Barroso, A, S Dunner, J Canon. “Technical Note: Use of PCR-single-strand conformation polymorphism analysis for detection of bovine beta-casein variants A1, A2, A3, and B”. Journal of Animal Science.1999. 77.10 (1999): 2629-2632. Print

Manga, I, J Dvorak. “TaqMan allelic discrimination assay for A1 and A2 alleles of the bovine CSN2 gene.” Czech Journal of Animal Science. 55.8 (2010): 307-312. Print

Kost, NV, OY Sokolov, MV Gabaeva, OB Kurasova, AD Dmitriev, JN Tarakanova, MV Gabaeva, YA Zolotarev, AK Dadayan, SA Grachev, EV Korneeva, IG Mikheeva, AA Zozulya. “Betacasomorphins-7 in infants on different type of feeding and different levels of psychomotor development.” Peptides. 30.10 (2009): 1854-1860. Print

Sokolov, O, N Kost, O Andreeva, E Korneeva, V Meshavkin, Y Tarakanova, A Dadayan, Y Zolotarev, S Grachev, I Mikheeva, O Varlamov, A Zozulya. “Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity.” Peptides. 56 (2014): 68-71. Print

Parashar, A, YS Rajput, R Sharma. “Aptamer-based sensing of betacasomorphin-7.” Journal of Agricultural and Food Chemistry. 63.10 (2015): 2647-2653. Print




DOI: http://dx.doi.org/10.21746/ijbio.2015.12.007

Refbacks

  • There are currently no refbacks.




Copyright (c) 2015 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.